Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.Show others and affiliations
2023 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 62, no 5, p. 431-437Article in journal (Refereed) Published
Abstract [en]
Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group's current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in these guidelines.
Place, publisher, year, edition, pages
Informa UK Limited Taylor & Francis, 2023. Vol. 62, no 5, p. 431-437
Keywords [en]
Lung, bronchopulmonary neoplasm, diagnosis, neuroendocrine carcinoma, neuroendocrine neoplasm, treatment
National Category
Cancer and Oncology Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:uu:diva-505319DOI: 10.1080/0284186X.2023.2212411ISI: 000990174700001PubMedID: 37194281OAI: oai:DiVA.org:uu-505319DiVA, id: diva2:1770339
2023-06-192023-06-192024-12-03Bibliographically approved